Latham & Watkins LLP represented Reddit in the offering. Reddit, Inc., a community of communities, has announced the pricing of its initial public offering of an...
You must be a Standard 1 Year member to access this content.
Cooley advised LegalZoom, Latham advised the underwriters, and Fried Frank advised the selling stockholder on the offering. LegalZoom.com, Inc. (Nasdaq: LZ) priced the previously announced underwritten...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised 4D Molecular Therapeutics, while Cooley advised the underwriters for the offering. 4D Molecular Therapeutics, Inc. has announced that it priced an upsized...
You must be a Standard 1 Year member to access this content.
Latham & Watkins is advising Revolution Medicines on the offering, and Davis Polk is advising the underwriters involved. Revolution Medicines, Inc. (Nasdaq: RVMD) has announced the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented UNITY Biotechnology in the transaction. UNITY Biotechnology, Inc. (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, has...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Bloom Energy in the transaction, while Davis Polk advised the underwriters. Bloom Energy Corporation (NYSE: BE), the developer of a solid-oxide platform for...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Revolution Medicines, while Davis Polk advised the underwriters in the offering. Revolution Medicines, Inc. (Nasdaq: RVMD), has announced the pricing of its underwritten...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering while Fenwick & West advised UserTesting, Inc. UserTesting, Inc., a leading provider of human insight, delivered through a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Mazanti-Andersen represented Ascendis Pharma A/S in the transaction. Ascendis Pharma A/S (Nasdaq: ASND) has announced the pricing of its underwritten public offering of...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised SentinelOne on the deal, while Latham & Watkins LLP represents the underwriters. SentinelOne, an autonomous cybersecurity platform company, announced its initial public...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented the initial purchasers in the offering . Snap Inc., a camera and social media company, executed its US$1 billion aggregate principal amount...
You must be a Standard 1 Year member to access this content.
